Curcumin Sleep Randomized Trial: What the Evidence Says

Quick Answer

Curcumin Sleep Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 randomized trial.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Pathophysiology has revealed that one of the primary risk factors for depression is chronic stress due to glucocorticoid effects on the hypothalamic-pituitary-adrenal (HPA) axis. [Cavanah Aidan M. (2026); evidence level 2]
• BDNF exerts neuroprotective and neuroactivating properties on both excitatory and inhibitory neurons, with high concentrations found in the hippocampus and frontal cortex. [Cavanah Aidan M. (2026); evidence level 2]
• Background Diabetic retinopathy (DR) is a significant complication of diabetes that can adversely affect the quality of life and anthropometric indices of individuals. [Amini S (2026); evidence level 2]
• This study aimed to investigate the impact of a combination of curcumin and piperine on mental health status (stress, anxiety, and depression), sleep quality, and anthropometric indices in patients with non-proliferative diabetic retinopathy. [Amini S (2026); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For curcumin sleep randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Cavanah Aidan M. (2026). A Randomized Controlled Trial to Determine the Effects of Curcumin and Epigallocatechin-3-Gallate Supplementation on Serum Brain-Derived Neurotrophic Factor and Mood Disturbance in Adults. DOI: 10.3390/nu18050855. PMCID: PMC12986582. PMID: 41830024. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12986582/
• Amini S (2026). The Effect of Curcumin Plus Piperine on Mental Health Status, Sleep Quality, and Anthropometric Indices in Patients with Non-Proliferative Diabetic Retinopathy: A Randomized Double-Blind Placebo-Controlled Trial.. DOI: 10.4103/ijpvm.ijpvm27623. PMCID: PMC13038278. PMID: 41924225. https://pmc.ncbi.nlm.nih.gov/articles/PMC13038278/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.